Thursday, August 14, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Stocks

Evotec Stock: Struggles Persist Despite Strategic Shifts

Dieter Jaworski by Dieter Jaworski
August 13, 2025
in Stocks
0
Evotec Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

German biotech firm Evotec continues to face financial headwinds, reporting a 5% revenue decline to €371 million in the first half of 2025. Its core business—drug discovery and preclinical development—plummeted by 11%, attributed to weak market demand. While its biologics subsidiary grew 16%, it failed to offset overall losses. Cost-cutting measures, including site closures and portfolio reductions, have fallen short, with adjusted EBITDA worsening to -€1.9 million. Analysts remain cautious, though some retain optimistic price targets.

Glimmers of Hope Amid Challenges

The company pins hopes on a pending €300 million sale of its Toulouse facility and strategic partnerships, including milestone payments from a major pharma collaborator. Management reaffirmed its full-year revenue forecast of €760–800 million but acknowledged a recovery in core operations may not materialize until 2026. Despite the bleak figures, shares rose 2.5%, reflecting investor patience with the turnaround plan.

Tags: Evotec
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Insmed Stock
Stocks

Insmed Stock: FDA Approval Sparks Bullish Surge

August 14, 2025
Air Canada Stock
Stocks

Air Canada Stock: Looming Strike Threatens Operations

August 14, 2025
Tencent Stock
Stocks

Tencent Stock: Gaming and AI Drive Record Surge

August 13, 2025
Next Post
Sixt Stock

Sixt Stock: Record Profits Fail to Impress Markets

Hellofresh Stock

Hellofresh Stock: Profit Warning Sparks Selloff

Tencent Stock

Tencent Stock: Gaming and AI Drive Record Surge

Recommended

Real Estate Investment Markets and money

Scotiabank Analyst Upgrades Healthpeak Properties Predicts Positive Future Performance

2 years ago
DrugRetailers Trading online

JP Morgan Analyst Shows Confidence in Lowes Companies with Price Target Increase

1 year ago
EEFT stock news

Opportunity to Purchase OPI Stock and Qualify for Dividend Payout

2 years ago
Electric Utilities Markets and money

Tanya MonizWitten Appointed President of San Jose Water

1 year ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Hellofresh Stock: Profit Warning Sparks Selloff

Sixt Stock: Record Profits Fail to Impress Markets

Evotec Stock: Struggles Persist Despite Strategic Shifts

Block Stock: $1.5 Billion Bond Offering Fuels Growth Plans

Jenoptik Stock: Profits Plunge Amid Semiconductor Slump

Pva Tepla Stock: Plunges on Disappointing Earnings

Trending

Insmed Stock
Stocks

Insmed Stock: FDA Approval Sparks Bullish Surge

by Robert Sasse
August 14, 2025
0

The FDA has granted approval for Insmed's Brinsupri as the first-ever treatment for non-cystic fibrosis bronchiectasis, a...

Air Canada Stock

Air Canada Stock: Looming Strike Threatens Operations

August 14, 2025
Tencent Stock

Tencent Stock: Gaming and AI Drive Record Surge

August 13, 2025
Hellofresh Stock

Hellofresh Stock: Profit Warning Sparks Selloff

August 13, 2025
Sixt Stock

Sixt Stock: Record Profits Fail to Impress Markets

August 13, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Insmed Stock: FDA Approval Sparks Bullish Surge August 14, 2025
  • Air Canada Stock: Looming Strike Threatens Operations August 14, 2025
  • Tencent Stock: Gaming and AI Drive Record Surge August 13, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com